| 产品详情 |
| Edit |   |
|---|
| Product Name | ML-18 |
|---|
| Description | A BB3 receptor antagonist; inhibits [125I]BA1 binding to NCI-H1299 lung cancer cells transfected with human BB3 receptors (IC50 = 4.8 µM); selective for BB3 over GRPR and NMBR (IC50s = 16 and >100 µM, respectively, in a radioligand binding assay); reversibly inhibits BA1-induced increases in cytosolic calcium in NCI-H1299 cells at 16 µM; inhibits BA1-induced phosphorylation of ERK and EGFR and reduces proliferation of NCI-H1299 cells |
|---|
| Size | 5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | CAS: 1422269-30-4 |
|---|
| Catalog # | 27319-5 |
|---|
| Price | |
|---|
| Order / More Info | ML-18 from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|